RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
2018-01-01 Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2013-01-01 Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer
2008-01-01 Santoro, A; Comandone, A; Rimassa, L; Granetti, C; Lorusso, V; Oliva, C; Ronzoni, M; Siena, S; Zuradelli, M; Mari, E; Pressiani, T; Carnaghi, C
A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer.
2014-01-01 Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma
2020-01-01 Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
2013-01-01 Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J
A pilot analysis of headache disorders in breast cancer patients
2021-01-01 De Sanctis, Rita; Viganò, Alessandro; Pindilli, Sebastiano; Torrisi, Rosalba; Santoro, Armando
A prospective observational study to evaluate G-CSF usage inpatients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.
2014-01-01 Barni, S; Lorusso, V; Giordano, M; Sogno, G; Gamucci, T; Santoro, A; Passalacqua, R; Iaffaioli, V; Zilembo, N; Mencoboni, M; Roselli, M; Pappagallo, G; Pronzato, P
A prospective study on survival in cancer patients with and without venous thromboembolism
2013-01-01 Agnelli, G; Verso, M; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino, L; Labianca, R
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma
2001-01-01 Gortzak, E; Azzarelli, A; Buesa, J; Bramwell, Vhc; van Coevorden, F; van Geel, An; Ezzat, A; Santoro, A; Oosterhuis, Jw; van Glabbeke, M; Kirkpatrick, A; Verweij, J
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma | 1-gen-2018 | Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M | |
| A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma | 1-gen-2013 | Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A | |
| A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer | 1-gen-2008 | Santoro, A; Comandone, A; Rimassa, L; Granetti, C; Lorusso, V; Oliva, C; Ronzoni, M; Siena, S; Zuradelli, M; Mari, E; Pressiani, T; Carnaghi, C | |
| A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer. | 1-gen-2014 | Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C | |
| A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma | 1-gen-2020 | Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A | |
| A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis | 1-gen-2013 | Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J | |
| A pilot analysis of headache disorders in breast cancer patients | 1-gen-2021 | De Sanctis, Rita; Viganò, Alessandro; Pindilli, Sebastiano; Torrisi, Rosalba; Santoro, Armando | |
| A prospective observational study to evaluate G-CSF usage inpatients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice. | 1-gen-2014 | Barni, S; Lorusso, V; Giordano, M; Sogno, G; Gamucci, T; Santoro, A; Passalacqua, R; Iaffaioli, V; Zilembo, N; Mencoboni, M; Roselli, M; Pappagallo, G; Pronzato, P | |
| A prospective study on survival in cancer patients with and without venous thromboembolism | 1-gen-2013 | Agnelli, G; Verso, M; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino, L; Labianca, R | |
| A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma | 1-gen-2001 | Gortzak, E; Azzarelli, A; Buesa, J; Bramwell, Vhc; van Coevorden, F; van Geel, An; Ezzat, A; Santoro, A; Oosterhuis, Jw; van Glabbeke, M; Kirkpatrick, A; Verweij, J |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 827
- 1 Contributo su Rivista::1.1 Arti... 734
- 2 Contributo in Volume 124
- 2 Contributo in Volume::2.1 Contr... 124
- 1 Contributo su Rivista::1.5 Abst... 84
- 4 Contributo in Atti di Convegno ... 47
- 4 Contributo in Atti di Convegno ... 35
- 3 Libro 15
- 3 Libro::3.1 Monografia o trattat... 15
- 4 Contributo in Atti di Convegno ... 10
- 1 Contributo su Rivista::1.2 Rece... 6
- 1 Contributo su Rivista::1.7 Lettera 3
- 4 Contributo in Atti di Convegno ... 2
Data di pubblicazione
- In corso di stampa 5
- 2020 - 2024 205
- 2010 - 2019 409
- 2000 - 2009 192
- 1990 - 1999 96
- 1982 - 1989 106
Editore
- Casa Editrice Ambrosiana 6
- SES 3
- EdiSES 2
- A. Giustina Ed 1
- Casa Edfitrice Ambrosiana 1
- Edizione Il Pensiero Scientifico ... 1
- Edizioni Minerva Medica 1
- EMP 1
- Forum per la Formazione Biomedica 1
- Piccini Nuova Libraria 1
Rivista
- ANNALS OF ONCOLOGY 96
- JOURNAL OF CLINICAL ONCOLOGY 86
- BONE MARROW TRANSPLANTATION 31
- EUROPEAN JOURNAL OF CANCER 24
- BLOOD 19
- THE LANCET ONCOLOGY 19
- HAEMATOLOGICA 15
- LUNG CANCER 15
- CANCERS 14
- BRITISH JOURNAL OF CANCER 13
Keyword
- Humans 29
- Female 15
- Middle Aged 13
- Male 12
- Adult 10
- Aged 10
- COVID-19 10
- immunotherapy 10
- breast cancer 9
- Antineoplastic Agents 8
Lingua
- eng 498
- ita 7
Accesso al fulltext
- no fulltext 811
- reserved 189
- open 13